Format

Send to

Choose Destination
Am J Infect Control. 2015 Jul 1;43(7):711-4. doi: 10.1016/j.ajic.2015.03.019. Epub 2015 Apr 29.

Efficiency of chlorhexidine-silver sulfadiazine-impregnated venous catheters at subclavian sites.

Author information

1
Department of Critical Care, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain. Electronic address: lorentemartin@msn.com.
2
Department of Microbiology and Infection Control, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.
3
Research Unit, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.
4
Department of Critical Care, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.

Abstract

BACKGROUND:

Cost-effectiveness analyses show that chlorhexidine-silver sulfadiazine (CHSS)-impregnated catheters reduce catheter-related bloodstream infection (CRBSI) and central venous catheter (CVC)-related costs. However, no studies have reported the efficiency of CHSS-impregnated catheters for venous access when the risk of CRBSI is low; for example, at the subclavian site. This study determined the cost of a CVC, diagnosis of CRBSI, and antimicrobial agents to treat CRBSI; we did not consider the cost of increased hospital stay.

METHODS:

This retrospective study included patients admitted to the intensive care unit at Hospital Universitario de Canarias (Tenerife, Spain) who had a subclavian venous catheter.

RESULTS:

Patients with CHSS catheters (n = 353) had a lower incidence density of CRBSI (2.12 vs 0 out of 1,000 catheter-days; P = .02) and lower CVC-related cost per catheter-day (3.35 ± 3.75 vs 3.94 ± 9.95; P = .002) than those with standard catheters (n = 518). CHSS-impregnated catheters were associated with a lower risk of CRBSI (exact logistic regression) (odds ratio, 0.10; 95% confidence interval, -∞ to 0.667; P = .008) than standard catheters when controlling for catheter duration. CHSS-impregnated catheters were also associated with a lower CVC-related cost per catheter day than standard catheters (Poisson regression) (odds ratio, 0.85; 95% confidence interval, 0.001-0.873; P < .001).

CONCLUSIONS:

CHSS-impregnated catheters may be efficient in preventing CRBSI in patients with subclavian venous access.

KEYWORDS:

Bacteremia; Central venous catheter

PMID:
25934065
DOI:
10.1016/j.ajic.2015.03.019
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center